本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Tyra Biosciences, Inc.

33.41
+0.73002.23%
盤後33.410.00000.00%17:40 EDT
成交量:107.79萬
成交額:3,581.57萬
市值:19.87億
市盈率:-15.34
高:33.91
開:32.68
低:32.20
收:32.68
52周最高:40.65
52周最低:8.88
股本:5,948.52萬
流通股本:2,507.09萬
量比:2.28
換手率:4.30%
股息:- -
股息率:- -
每股收益(TTM):-2.1777
每股收益(LYR):-2.0125
淨資產收益率:-36.87%
總資產收益率:-23.64%
市淨率:5.13
市盈率(LYR):-16.60

資料載入中...

2025/05/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/09

重要事件披露

Form 8-K - Current report
2025/03/27

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/27

重要事件披露

Form 8-K - Current report
2025/02/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/29

重要事件披露

Form 8-K - Current report
2025/01/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/06

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/12/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/19

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/08

重要事件披露

Form 8-K - Current report